It could be hypothesized that following stimulation via PSMA the prostate tumor cells augment IL-6 and CCL5 production which are in turn used as growth factors in both autocrine and paracrine manner, triggering a cell proliferation/survival loop conferring resistance to apoptosis and an overall definite advantage to tumor cell populations. The gene discussed is FOLH1; the disease is prostate neoplasm.